Deyali Chatterjee, MD

Chief Resident
Department of Pathology and Immunology
Baylor College of Medicine
1 Baylor Plaza, Houston, TX 77030, USA

 

Biography

Dr. Chatterjee obtained her medical degree (M.B.B.S) from Calcutta Medical College in 2000, followed by a pathology residency (M.D.) from Banaras Hindu University (2001-2004), both in India. She then worked in Singapore as a Clinical Associate (2005-2006) and Registrar (2006-2009) in surgical pathology before moving to the USA (2010). Before joining residency in anatomic pathology at Baylor College of Medicine (2013), she did three years of postdoctoral research fellowship at University of Texas MD Anderson Cancer Center (2010-2013), working on various aspects of histologic changes with neoadjuvant therapy in pancreatic ductal adenocarcinomas. In September 2014, Dr. Chatterjee was elected as an associate chief resident and is currently serving as a chief resident in the Department of Pathology and Immunology at Baylor College of Medicine. She has accepted a one-year fellowship at the University of Texas MD Anderson Cancer Center to pursue gastrointestinal pathology, due to start in July 2016.
Dr. Chatterjee has a strong research interest, with 23 peer-reviewed publications in prestigious journals including Cancer, American Journal of Surgical Pathology, Human Pathology, Clinical Cancer Research, PLoS One, etc. She has presented about 16 abstracts in various state and national level meetings, including two platform presentations at the USCAP (2012 and 2014). She has received the best poster award at the Trainee Research Symposium at Baylor College of Medicine (2014) and is a recipient of Texas Society of Pathologists Education Foundation Scholarship (2015). Her research interests include liver and gastrointestinal pathology.

Research Interest

Her research interest includes: Gastrointestinal and Liver pathology.

Scientific Activities

HONORS AND AWARDS

• (2015) Education Foundation Scholarship Texas Society of Pathologists
• (2014) Best poster presentation, Trainee Research Symposium Baylor College of Medicine, Department of Pathology
• (2014) Certificate of Achievement in recognition of outstanding participation by a 1st year resident, Holiday Pedi Path Quiz Bowl Department of Pathology, Texas Childrens Hospital
• (2000) 2nd Runner-up, Regional inter-collegiate Medi-quiz competition Glaxo-Wellcome (India)
• (1998) Senior Class Assistant (Internal Medicine) Calcutta Medical College, Kolkata
• (1997-1998) Honors student (Pharmacology) Calcutta Medical College, Kolkata
• (1996-1997) Maharaja Gwalior prize for highest aggregate score in medical school University of Calcutta
• (1996-1997) University Gold Medallist University of Calcutta
• (1995-1996) Honors student (Physiology) Calcutta Medical College, Kolkata
• (1994) Senior Scholar Jagadish Bose National Science Talent Search, Govt. of West Bengal
• (1992) Scholar, National Talent Search National Council of Educational Research & Training, Govt. of India

Publications

1. Chatterjee D. Liquid biopsies: Handle with care. Pathol Lab Med Open J. 2016; 1(1): 3-6. http://openventio.org/Volume1-Issue1/Liquid-Biopsies-Handle-With-Care-PLMOJ-1-102.pdf
2. Xia M, Overman MJ, Rashid A, et al. Expression and clinical significance of epidermal growth factor receptor and insulin-like growth factor receptor 1 in patients with ampullary adenocarcinoma. Hum Pathol. 2015; 46(9): 1315-1322. doi: 10.1016/j.humpath.2015.05.012
3. Chatterjee D, Finch C. Sclerosing Thymoma. Arch Pathol Lab Med. 2015; 139(8): 1068-1070.
4. Ayala G, Frolov A, Chatterjee D, He D, Hilsenbeck S, Ittmann M. Expression of ERG protein in prostate cancer: Variability and biological correlates. Endocr Relat Cancer. 2015; 22(3): 277-287. doi: 10.1530/ERC-14-0586.
5. Roland CL, Yang AD, Katz MH, et al. Neoadjuvant Therapy is Associated with a Reduced Lymph Node Ratio in Patients with Potentially Resectable Pancreatic Cancer. Ann Surg Oncol. 2015; 22(4): 1168-1175. doi: 10.1245/s10434-014-4192-6
6. Kang Y, Zhang R, Suzuki R, et al. Two-dimensional culture of humanpancreatic adenocarcinoma cells results in an irreversible transition from epithelial to mesenchymal phenotype. Lab Invest. 2015; 95(2): 207-222. doi: 10.1038/labinvest.2014.143.
7. Li X, Truty MA, Kang Y, et al. Extracellular lumican inhibits pancreatic cancer cell growth and is associated with prolonged survival after surgery. Clin Cancer Res. 2014; 20(24): 6529-6540. doi: 10.1158/1078-0432.CCR-14-0970.
8. Thomas RM, Truty MJ, Kim M, et al. The Canary in the Coal Mine: The Growth of Patient-Derived Tumorgrafts in Mice Predicts Clinical Recurrence after Surgical Resection of Pancreatic DuctalAdenocarcinoma. Ann Surg Oncol. 2014; 18. doi: 10.1245/s10434-014-4241-1
9. Chatterjee D, Wang H. Mixed Adenoneuroendocrine Carcinoma Arising in a Papillary Adenoma of Gallbladder. American Journal of Cancer Case Reports. 2014; 2(1): 37-42.
10. Kang Y, Ling J, Suzuki R, et al. SMAD4 regulates cell motility through transcription of N-cadherin in human pancreatic ductal epithelium. PLoS One. 2014; 9(9): e107948. doi: 10.1371/journal.pone.0107948
11. Wang H, Estrella JS, Chatterjee D, et al. Hepatobiliary/Pancreas Pathology: SY11-3 pancreatic ductal adenocarcinoma: Neoadjuvant therapies and pathology. Pathology. 2014; 46(Suppl 2): S25. doi: 10.1097/01.pat.0000454135.19954.47
12. Koay EJ, Baio F, Ondari A, et al. Intra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer. Physical biology. 2014; 11(6). doi: 10.1088/1478-3975/11/6/065002
13. Guo R, Shroff S, Rashid A, et al. Aberrant expression of p53, p21, cyclin D1 and Bcl2 and their clinicopathologic correlation in ampullary adenocarcinoma. Human Pathology. 2014; 45(5): 1015-1023.
14. Koay EJ, Truty MJ, Cristini V, et al. Transport properties of pancreatic cancer describe gemcitabine delivery and response. Journal of Clinical Investigation. 2014; 124(4): 1525-1536. doi: 10.1172/JCI73455.
15. Philip B, Roland CL, Daniluk J, et al. A high-fat diet activates oncogenic Kras and COX2 to induce development of pancreatic ductal adenocarcinoma in mice. Gastroenterology. 2013; 145(6): 1449-1458. doi: 10.1053/j.gastro.2013.08.018
16. Chatterjee D, Katz MH, Rashid A, et al. Pancreatic Intraepithelial Neoplasia and Histologic Changes in Benign Pancreas Associated with Neoadjuvant Therapy in Patients with Pancreatic Ductal Adenocarcinoma. Histopathology. 2013; 63(6): 841-851. doi: 10.1111/his.12234
17. Shroff S, Overman MJ, Rashid A, et al. The Expression of PTEN Is Associated With Improved Prognosis in Patients With Ampullary Adenocarcinoma After Pancreaticoduodenectomy. Archives of Pathology & Laboratory Medicine. 2013; 137(11): 1619-1626. doi: 10.5858/arpa.2012-0418-OA
18. Chang Z, Li Z, Kang Y, et al. Deciphering the mechanisms of tumorigenesis in human pancreatic ductal epithelial cells. Clinical Cancer Research. 2013; 19(3): 549-559. doi: 10.1158/1078-0432.CCR-12-0032
19. Weng S, Wang H, Chen W, et al. Over expression of Protein Phosphatase 4 Correlates with Poor Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma. Cancer Epidemiology Biomarkers and Prevention. 2012; 21(8): 1336-1343. doi: 10.1158/1055-9965.EPI-12-0223
20. Chatterjee D, Katz MH, Rashid A, et al. Histologic grading the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma: A predictor for patient outcome. Cancer. 2012; 118(12): 3182-3190. doi: 10.1002/cncr.26651
21. Chatterjee D, Rashid A, Wang H, et al. Tumor invasion of muscular vessels predicts poor prognosis in patients with pancreatic ductal adenocarcinoma who have received neoadjuvant therapy and pancreaticoduodenectomy. American Journal of Surgical Pathology. 2012; 36(4): 552-559. doi: 10.1097/PAS.0b013e318240c1c0
22. Chatterjee D, Katz MH, Rashid A, et al. Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinoma. American Journal of Surgical Pathology. 2012; 36(3): 409-417. doi: 10.1097/PAS.0b013e31824104c5
23. Puvanakrishnan P, Park J, Chatterjee D, Krishnan S, Tunnell JW. In vivo tumor targeting of gold nanoparticles: effect of particle type and dosing strategy. International Journal of Nanomedicine. 2012; 7: 1251-1258. doi: 10.2147/IJN.S29147.
24. Lee J, Ng C, Chatterjee D. Cytomegalovirus colitis presenting as massive lower gastrointestinal bleeding in an immunocompetent patient. Indian Journal of Surgery. 2008; 70(1): 28-31. doi: 10.1007/s12262-008-0006-z